PortfoliosLab logoPortfoliosLab logo
ISIN
US80880X1046
IPO Date
Apr 27, 2010

Highlights

Market Cap
$155.17M
Enterprise Value
-$3.37B
EPS (TTM)
-$303.01
Total Revenue (TTM)
$56.75M
Gross Profit (TTM)
$54.17M
EBITDA (TTM)
-$3.54B
Year Range
$0.24 - $2.60
ROA (TTM)
-55.68%
ROE (TTM)
-67.21%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Scienture Holdings, Inc

Often compared with SCNX:
SCNX vs. RZLVSCNX vs. MSAI

Performance

SCNX Performance Chart

Scienture Holdings, Inc (SCNX) is down 25.1% since the beginning of the year. At $0 per share, SCNX is trading 85.3% below its 52-week high of $3. Investors who bought $1,000 worth of SCNX shares 5 years ago would now be looking at an investment worth $9.


Loading charts...

S&P 500 Index

Returns By Period

Scienture Holdings, Inc (SCNX) has returned -25.12% so far this year and -58.09% over the past 12 months. Over the last ten years, SCNX has returned -38.89% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Scienture Holdings, Inc

1D
0.03%
1M
-5.00%
YTD
-25.12%
6M
-26.75%
1Y
-58.09%
3Y*
-58.28%
5Y*
-61.19%
10Y*
-38.89%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SCNX Monthly Returns History

Based on dividend-adjusted daily data since Apr 27, 2010, SCNX's average daily return is +4.74%, while the average monthly return is +380.64%. At this rate, an investment would double in approximately 0.0 years.

Historically, 37% of months were positive and 63% were negative. The best month was May 2014 with a return of +73,650.0%, while the worst month was Jun 2011 at -63.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, SCNX closed higher 24% of trading days. The best single day was May 9, 2014 with a return of +14,900.0%, while the worst single day was Dec 1, 2011 at -76.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-10.92%-5.33%-33.74%37.19%5.63%-7.53%-25.12%
2025-36.03%-31.52%-45.66%-35.42%-5.99%18.95%86.54%-49.74%-12.87%-8.65%-22.80%-14.87%-91.57%
2024-19.75%128.30%61.11%-41.80%10.23%70.02%-7.13%-18.39%-4.05%-3.03%0.00%-17.69%86.89%
20234.37%-0.86%-29.19%13.27%-16.21%210.71%-43.14%2.96%-7.98%-17.21%0.52%-11.17%-13.95%
2022-13.98%-13.30%57.39%-38.63%-8.92%4.62%2.47%-30.12%-2.59%-21.24%-36.52%-28.74%-82.94%
20214.54%13.02%-16.16%-16.98%-16.78%22.10%12.44%8.25%-8.48%-13.07%-22.66%-28.70%-55.39%

Benchmark Metrics

Scienture Holdings, Inc has an annualized alpha of 10936900.32%, beta of 0.48, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 27, 2010.

  • This stock participated in 226.34% of S&P 500 Index downside but only 188.45% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.48 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
10,936,900.32%
Beta
0.48
0.00
Upside Capture
188.45%
Downside Capture
226.34%

Return for Risk

Risk / Return Rank

SCNX ranks 48 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


SCNX Risk / Return Rank: 4848
Overall Rank
SCNX Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SCNX Sortino Ratio Rank: 7777
Sortino Ratio Rank
SCNX Omega Ratio Rank: 8282
Omega Ratio Rank
SCNX Calmar Ratio Rank: 1818
Calmar Ratio Rank
SCNX Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Scienture Holdings, Inc (SCNX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SCNXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.18

Sortino ratioReturn per unit of downside risk

-0.69

Omega ratioGain probability vs. loss probability

1.31

1.37

-0.06

Calmar ratioReturn relative to maximum drawdown

-0.64

2.78

-3.43

Martin ratioReturn relative to average drawdown

-0.81

12.44

-13.25

Dividends

Dividend History

Scienture Holdings, Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%50.00%100.00%150.00%$0.00$2.00$4.00$6.00$8.00$10.0020242025
Dividends
Dividend Yield
PeriodTTM20252024
Dividend$0.00$0.00$9.50

Dividend yield

0.00%0.00%157.02%

Monthly Dividends

The table displays the monthly dividend distributions for Scienture Holdings, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$8.00$0.00$0.00$0.00$1.50$0.00$0.00$0.00$0.00$0.00$9.50

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Scienture Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Scienture Holdings, Inc was 99.85%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Scienture Holdings, Inc drawdown is 99.77%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.85%Mar 2026
11y 10mo
12y 23dJun 2014 - now
2012 bear market2012
-99.50%May 2012
2y 25d1y 11mo
4y 10dApr 2010 - May 2014

Drawdown Indicators


SCNXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.85%

-56.78%

-43.07%

Max Drawdown (1Y)

Largest decline over 1 year

-90.73%

-9.10%

-81.63%

Max Drawdown (3Y)

Largest decline over 3 years

-98.86%

-18.90%

-79.96%

Max Drawdown (5Y)

Largest decline over 5 years

-99.64%

-25.43%

-74.21%

Max Drawdown (10Y)

Largest decline over 10 years

-99.74%

-33.92%

-65.82%

Current Drawdown

Current decline from peak

-99.77%

-1.80%

-97.97%

Average Drawdown

Average peak-to-trough decline

-81.80%

-10.71%

-71.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

71.44%

2.03%

+69.41%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Scienture Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Scienture Holdings, Inc is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SCNX relative to other companies in the Pharmaceutical Retailers industry. Currently, SCNX has a P/S ratio of 1.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SCNX in comparison with other companies in the Pharmaceutical Retailers industry. Currently, SCNX has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with SCNX

Add Scienture Holdings, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with SCNX